Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- Sweden
- Spain
- France
- Portugal
- Netherlands
- Belgium
- Poland
- Denmark
- Czech
- Morocco
- Singapore
- Canada
- Norway
- Switzerland
- Austria
- Finland
- China
- Hong Kong
- United Arab Emirates
- Brazil
- Greece
- Australia
- Italy
- Ireland
- Luxembourg
- Japan
- Lithuania
- Israel
- Andorra
- Bulgaria
- Croatia
- Estonia
- Europe
- India
- Malaysia
- Malta
- Mexico
- Romania
- Taiwan
- 32 more »
- « less
-
Program
-
Field
-
the world. The Biomedical Informatics and Genetic Phenotype Redefinition Research Group at the Institute of Clinical Molecular Biology (IKMB), Kiel University (CAU) and the University Medical Center Schleswig
-
at the organismal, cellular and molecular levels. The successful candidate will join the group of Dr Jan Perner (Laboratory of Molecular Biology of Ticks), see more here: https://www.paru.cas.cz/en/sections/disease
-
on developing and interrogating novel therapies for prostate cancer. These experiments would include molecular engineering/alteration and interrogation of prostate cancer cell line models, RNA-seq/ChIP-seq, etc
-
antibody construct in the murine model of cigarette-smoke induced airway inflammation. Funding category: Financement public/privé FNRS PHD title: PhD in biomedical and pharmaceutical sciences PHD Country
-
(https://engels45.wixsite.com/engelslab ) is looking for highly motivated students to participate in research aimed at deciphering the molecular mechanisms of neurodegenerative diseases (NDDs), such as
-
multidisciplinary approaches, including advanced bio-imaging, image analysis, cell biology, genetics, and molecular biology. Find out more about our research group here: https://tymri.ut.ee/en/content/developmental
-
Carl von Ossietzky Universität Oldenburg | Oldenburg Oldenburg, Niedersachsen | Germany | 3 days ago
experience, with the genetic (and general scientific) model organism Drosophila, especially regarding its genetics and molecular biology. Practical experience must be evidenced by at least one relevant first
-
regulators of signalling, biomechanics and defence. Yet we still don’t have a mechanistic understanding of how wall remodelling events are controlled at the molecular level, how they integrate with stress
-
mechanisms of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and ALS. Our research utilizes a multidisciplinary approach incorporating mouse models, molecular/cellular biology
-
processes at the molecular, cellular, tissue and systems level of organisation. In so doing we provide a bridge to translational medicine, and interface between physical and life sciences. We are committed